tiprankstipranks
Advertisement
Advertisement
Erasca enters AURORAS-1 clinical trial pact, supply agreement with Merck
PremiumThe FlyErasca enters AURORAS-1 clinical trial pact, supply agreement with Merck
10d ago
Erasca recent share selloff overdone, says JPMorgan
Premium
The Fly
Erasca recent share selloff overdone, says JPMorgan
17d ago
H.C. Wainwright sees pressure for Erasca shares pending safety visibility
Premium
The Fly
H.C. Wainwright sees pressure for Erasca shares pending safety visibility
23d ago
Erasca falls after disclosing patient died after withdrawing from trial
PremiumThe FlyErasca falls after disclosing patient died after withdrawing from trial
23d ago
Erasca price target raised to $9 from $2 at BofA
Premium
The Fly
Erasca price target raised to $9 from $2 at BofA
23d ago
Analyst Maintains Buy on ERAS-0015’s Promising Early Data, Keeps Price Target Unchanged at $20
Premium
Ratings
Analyst Maintains Buy on ERAS-0015’s Promising Early Data, Keeps Price Target Unchanged at $20
23d ago
Erasca falls -9.9%
PremiumThe FlyErasca falls -9.9%
24d ago
Erasca sinks after Revolution Medicines alleges patent infringement
Premium
The Fly
Erasca sinks after Revolution Medicines alleges patent infringement
24d ago
Erasca Highlights ERAS-0015 Phase 1 Data Update
Premium
Company Announcements
Erasca Highlights ERAS-0015 Phase 1 Data Update
24d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100